JP2024541315A - 中枢性低換気に関連する状態を治療するための方法および組成物 - Google Patents

中枢性低換気に関連する状態を治療するための方法および組成物 Download PDF

Info

Publication number
JP2024541315A
JP2024541315A JP2024527312A JP2024527312A JP2024541315A JP 2024541315 A JP2024541315 A JP 2024541315A JP 2024527312 A JP2024527312 A JP 2024527312A JP 2024527312 A JP2024527312 A JP 2024527312A JP 2024541315 A JP2024541315 A JP 2024541315A
Authority
JP
Japan
Prior art keywords
pharma
acceptable salt
nri
pharmaceutical composition
cai
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024527312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541315A5 (cg-RX-API-DMAC7.html
Inventor
タラント-モンテムッロ,ルイージ
ホワイト,デービッド,ピー.
ファーカス,ロナルド
ミラー,ローレンス,ジー.
Original Assignee
アプニメッド,インコーポレイテッド(デラウェア)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アプニメッド,インコーポレイテッド(デラウェア) filed Critical アプニメッド,インコーポレイテッド(デラウェア)
Publication of JP2024541315A publication Critical patent/JP2024541315A/ja
Publication of JP2024541315A5 publication Critical patent/JP2024541315A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024527312A 2021-11-11 2022-11-10 中枢性低換気に関連する状態を治療するための方法および組成物 Pending JP2024541315A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163278324P 2021-11-11 2021-11-11
US63/278,324 2021-11-11
US202263305305P 2022-02-01 2022-02-01
US63/305,305 2022-02-01
PCT/US2022/049483 WO2023086433A1 (en) 2021-11-11 2022-11-10 Methods and compositions for treating conditions associated with central hypoventilation

Publications (2)

Publication Number Publication Date
JP2024541315A true JP2024541315A (ja) 2024-11-08
JP2024541315A5 JP2024541315A5 (cg-RX-API-DMAC7.html) 2025-11-17

Family

ID=84627454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527312A Pending JP2024541315A (ja) 2021-11-11 2022-11-10 中枢性低換気に関連する状態を治療するための方法および組成物

Country Status (9)

Country Link
US (1) US20250000823A1 (cg-RX-API-DMAC7.html)
EP (1) EP4429649A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024541315A (cg-RX-API-DMAC7.html)
KR (1) KR20240108453A (cg-RX-API-DMAC7.html)
AU (1) AU2022387440A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237151A1 (cg-RX-API-DMAC7.html)
IL (1) IL312688A (cg-RX-API-DMAC7.html)
MX (1) MX2024005600A (cg-RX-API-DMAC7.html)
WO (1) WO2023086433A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025207125A1 (en) * 2024-03-26 2025-10-02 The Regents Of The University Of California Combination pharmacological interventions for obstructive sleep apnea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP3685858A1 (en) * 2019-01-24 2020-07-29 Assistance Publique-Hopitaux De Paris A noradrenergic system stimulator in the treatment of central hypoventilation syndromes
US20220362221A1 (en) * 2019-11-04 2022-11-17 Apnimed, Inc. (Delaware) Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea

Also Published As

Publication number Publication date
US20250000823A1 (en) 2025-01-02
EP4429649A1 (en) 2024-09-18
WO2023086433A1 (en) 2023-05-19
MX2024005600A (es) 2024-05-21
KR20240108453A (ko) 2024-07-09
CA3237151A1 (en) 2023-05-19
AU2022387440A1 (en) 2024-05-23
IL312688A (en) 2024-07-01

Similar Documents

Publication Publication Date Title
JP6074003B2 (ja) パーキンソン病の治療におけるオピオイド作動薬とオピオイド拮抗薬との組合せ
JP5416085B2 (ja) 下痢型および交替型過敏性腸症候群の処置のためのカッパ−オピエートアゴニスト
US20220226288A1 (en) Dexmedetomidine treatment regimens
AU2016219650B2 (en) Compositions and methods for extended therapy with aminopyridines
US20110070319A1 (en) Bifeprunox doses for treating schizophrenia
US20230181583A1 (en) Treating liver disorders with an ssao inhibitor
TW200831097A (en) Treatment of anxiety with eszopiclone
CN117177741A (zh) 用于治疗睡眠呼吸暂停的去甲肾上腺素再摄取抑制剂和大麻素的组合
KR20240108453A (ko) 중추성 저환기와 관련된 질환을 치료하기 위한 방법 및 조성물
TW201828937A (zh) 供治療重症肌無力及其他肌無力症候群之用途及組合物
CN117956959A (zh) 用于治疗睡眠呼吸暂停的方法和组合物
CN118695856A (zh) 用于治疗与中枢性通气不足相关的疾患的方法和组合物
CN117062626A (zh) 用于治疗睡眠呼吸暂停的方法和组合物
JP2024523876A (ja) 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤
JP2019528261A (ja) ヒスタミン−3受容体インバースアゴニスト、アセチルコリンエステラーゼ阻害剤及びnmda受容体アンタゴニストの3種組合せ
JP7556031B2 (ja) 認知症患者の行動心理学的症状の治療
AU2024379175A1 (en) Methods and compositions for treating sleep apnea with a combination of a glp-1 agonist and a second active agent
JP5376481B1 (ja) 経皮吸収用医薬組成物
IL230174A (en) Pharmaceutical composition for the treatment of premature ejaculation
US20240398771A1 (en) Treatment of scleroderma and raynaud's syndrome
WO2025162430A1 (zh) 一种药物联用及其在预防或治疗神经退行性疾病中的用途
EA045669B1 (ru) Способы лечения поведенческих и психологических симптомов у пациентов с деменцией
HK40112834A (en) Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
WO2026025110A1 (en) Treatment of refractory chronic cough
WO2021146425A1 (en) Methods of treating acute muscle spasms

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251107

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251107